Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	893	457	356	113	71	106
Market Cap Growth	92.09%	28.56%	216.20%	57.37%	-32.32%	-46.55%
Enterprise Value	904.32	462.44	370.75	91.15	60.68	96.52
Last Close Price	32.59	16.91	13.32	4.38	2.82	4.29
Forward PE	36.34	30.56	57.91	79.64	-	9.98
PS Ratio	10.27	5.72	9.12	3.56	3.36	4.84
PB Ratio	29.12	17.49	14.56	7.27	5.47	5.99
P/TBV Ratio	31.02	17.40	14.12	7.26	5.42	6.13
P/FCF Ratio	57.85	44.88	377.27	16.51	14.95	-
P/OCF Ratio	56.36	43.46	367.15	16.51	14.83	-
EV/Sales Ratio	10.40	5.78	9.50	2.88	2.86	4.42
EV/EBITDA Ratio	81.58	144.51	-	-	-	-
EV/FCF Ratio	58.60	45.38	393.16	13.37	12.69	-
Debt / Equity Ratio	1.02	1.19	1.22	0.00	0.42	0.30
Debt / EBITDA Ratio	5.03	9.69	-	-	-	-
Debt / FCF Ratio	2.02	3.04	31.73	0.79	1.36	-
Net Debt / Equity Ratio	0.38	0.19	0.61	-1.03	-0.75	-0.44
Net Debt / EBITDA Ratio	1.86	1.59	-10.32	54.94	1.51	7.47
Net Debt / FCF Ratio	0.75	0.50	15.89	-2.35	-2.04	1.63
Asset Turnover	0.92	0.95	0.72	1.11	0.81	0.81
Inventory Turnover	2.63	2.43	1.93	14.42	12.53	3.16
Quick Ratio	0.75	0.98	1.02	1.53	2.81	4.36
Current Ratio	1.21	1.57	2.06	1.65	3.10	5.18
Return on Equity (ROE)	-5.20%	-18.19%	-19.16%	-6.56%	-58.75%	-11.74%
Return on Assets (ROA)	2.13%	-1.01%	-4.83%	-5.70%	-31.47%	-5.56%
Return on Invested Capital (ROIC)	4.93%	-2.19%	-12.80%	-116.16%	-125.00%	-26.16%
Return on Capital Employed (ROCE)	3.81%	-1.54%	-7.25%	-7.00%	-39.83%	-6.58%
FCF Yield	1.73%	2.23%	0.27%	6.06%	6.69%	-
Buyback Yield / Dilution	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%
Total Shareholder Return	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q